THE cure for cancer has so far proved elusive, and with 10 million people diagnosed each year, the need for medical and pharmaceutical companies to come up with results is crucial. One Chinese company, the Yantai Medgenn Corporation, in Yantai, Shandong Province, hopes to be getting close with its genetic medicine, YH-16. This company will be putting its product on the market next summer, having been aided greatly by the nurturing business environment cultivated bv the citv of Yantai.